STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia
Clinical trial NCT05490563 · TERMINATED
Trial details
- NCT number
- NCT05490563
- Sponsor
- Seelos Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-03
- Primary completion
- 2023-11-24
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.